Literature DB >> 19362250

Pelvic radiotherapy for cancer of the cervix: is what you plan actually what you deliver?

Karen Lim1, Valerie Kelly, James Stewart, Jason Xie, Young-Bin Cho, Joanne Moseley, Kristy Brock, Anthony Fyles, Anna Lundin, Henrik Rehbinder, Michael Milosevic.   

Abstract

PURPOSE: Whole pelvic intensity-modulated radiotherapy (IMRT) is increasingly being used to treat cervix cancer and other gynecologic tumors. However, tumor and normal organ movement during treatment can substantially detract from the benefits of this approach. This study explored the effect of internal anatomic changes on the dose delivered to the tumor and organs at risk using a strategy integrating deformable soft-tissue modeling with simulated dose accumulation. METHODS AND MATERIALS: Twenty patients with cervix cancer underwent baseline and weekly pelvic magnetic resonance imaging during treatment. Interfraction organ motion and delivered (accumulated) dose was modeled for three treatment scenarios: four-field box, large-margin whole pelvic IMRT (20-mm planning target volume, but 10 mm inferiorly) and small-margin IMRT (5-mm planning target volume).
RESULTS: Individually, the planned dose was not the same as the simulated delivered dose; however, when taken as a group, this was not statistically significant for the four-field box and large-margin IMRT plans. The small-margin IMRT plans yielded adequate target coverage in most patients; however, significant target underdosing occurred in 1 patient who displayed excessive, unpredictable internal target movement. The delivered doses to the organs at risk were significantly reduced with the small-margin plan, although substantial variability was present among the patients.
CONCLUSION: Simulated dose accumulation might provide a more accurate depiction of the target and organ at risk coverage during fractionated whole pelvic IMRT for cervical cancer. The adequacy of primary tumor coverage using 5-mm planning target volume margins is contingent on the use of daily image-guided setup.

Entities:  

Mesh:

Year:  2009        PMID: 19362250     DOI: 10.1016/j.ijrobp.2008.12.043

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  25 in total

1.  Risk factors related to interfractional variation in whole pelvic irradiation for locally advanced pelvic malignancies.

Authors:  W S Yoon; D S Yang; J A Lee; S Lee; Y J Park; C Y Kim
Journal:  Strahlenther Onkol       Date:  2012-02-10       Impact factor: 3.621

2.  The effect of uterine motion and uterine margins on target and normal tissue doses in intensity modulated radiation therapy of cervical cancer.

Authors:  J J Gordon; E Weiss; O K Abayomi; J V Siebers; N Dogan
Journal:  Phys Med Biol       Date:  2011-04-13       Impact factor: 3.609

Review 3.  Problems and solutions in IGRT for cervical cancer.

Authors:  Iván Ríos; Ilse Vásquez; Elsa Cuervo; Óscar Garzón; Johnny Burbano
Journal:  Rep Pract Oncol Radiother       Date:  2018-05-26

Review 4.  Image-guided radiotherapy: from current concept to future perspectives.

Authors:  David A Jaffray
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

5.  Utility and validation of biomechanical deformable image registration in low-contrast images.

Authors:  Michael Velec; Titania Juang; Joanne L Moseley; Mark Oldham; Kristy K Brock
Journal:  Pract Radiat Oncol       Date:  2015-03-29

6.  An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography.

Authors:  Xin Wang; Min Yu; Jin Wang; Renming Zhong; Yali Shen; Yaqin Zhao; Zhiping Li; Sen Bai; Feng Xu
Journal:  Mol Clin Oncol       Date:  2015-12-10

Review 7.  The role of intensity modulated radiotherapy in gynecological radiotherapy: Present and future.

Authors:  Ana Fernandez-Ots; Juanita Crook
Journal:  Rep Pract Oncol Radiother       Date:  2013-10-03

8.  Variability in clinical target volume delineation for intensity modulated radiation therapy in 3 challenging cervix cancer scenarios.

Authors:  Karen Lim; Beth Erickson; Ina M Jürgenliemk-Schulz; David Gaffney; Carien L Creutzberg; Akila Viswanathan; Lorraine Portelance; Sushil Beriwal; Aaron Wolfson; Walter Bosch; Jennifer De Los Santos; Catheryn Yashar; Anuja Jhingran; Mahesh Varia; Issam El Naqa; Bronwyn King; Anthony Fyles
Journal:  Pract Radiat Oncol       Date:  2015-07-02

9.  Accumulated dose in liver stereotactic body radiotherapy: positioning, breathing, and deformation effects.

Authors:  Michael Velec; Joanne L Moseley; Tim Craig; Laura A Dawson; Kristy K Brock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-12-28       Impact factor: 7.038

10.  Prospective Validation of a High Dimensional Shape Model for Organ Motion in Intact Cervical Cancer.

Authors:  Casey W Williamson; Garrett Green; Sonal S Noticewala; Nan Li; Hanjie Shen; Florin Vaida; Loren K Mell
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-08-22       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.